Capital Flow Monitor · Sponsors · CIK 803578
FIREFLY NEUROSCIENCE, INC.
1100 MILITARY ROAD, KENMORE, NY, 14217 · 888-237-6412
Other Health Care · Corporation· inc. DELAWARE true 2022
Fit score
—
Offering
$20.3M
Sold
$2.3M
% sold
11.1%
Investors
6
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | D ·current | 506(b) | $20.3M | $2.3M | 11.1% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Paul Krzywicki — Executive Officer, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Arun Menawat — Director, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Greg Lipshitz — Executive Officer / Director, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Gil Issachar — Executive Officer, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
David DeCaprio — Executive Officer / Director, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Brian Posner — Director, Kenmore, NY
1 other raise
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
-
Stella Vnook — Director, Kenmore, NY
2 other raises
- Kaida BioPharma Inc. $1.6M of $4.1M · 39.0%
- Firefly Neuroscience, Inc. $2.3M of $20.3M · 11.1%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.